Avid Bioservices Inc (CDMO)

[biopharm]

Thx and I just wonder what % PS Targeting IP will capture if the overall market of the IP, which may extend into more areas than we initially think.

As for just cancer diagnostics ... do I hear more than $200 Billion ? and I believe once the market realizes we have cures here NOW, instead of spending 80+% of the insurance on end of life treatment that does more killing than saving, markets will flip and we will start shifting that 80+% number to the front end where we sit and monitor very closely via a tidal wave of new monitoring devices such as Biosensors in clothing....etc and if Exosomes are the most effective way to monitor and flipped PS being required, I bet we have much more than residual value.

Cancer Diagnostics Market Worth $232.7 Billion By 2025 | CAGR: 7.2%
March 2017 | Report Format: Electronic (PDF)

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.
...
...
...

https://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market